YUMAB Trademark

Trademark Overview


On Monday, April 25, 2016, a trademark application was filed for YUMAB with the United States Patent and Trademark Office. The USPTO has given the YUMAB trademark a serial number of 79191669. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, September 27, 2024. This trademark is owned by YUMAB GmbH. The YUMAB trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Antibodies, antibody fragments and antigens in the nature of pharmaceuticals for the treatment of cancer, haematopoietic diseases, autoimmune diseases, neurodegenerative diseases, metabolic diseases, eye diseases, infections, diseases of heart and circulation, bone diseases, transplantation, sepsis, intoxications, and adverse drug reactions

[ Monoclonal antibodies for quantitative determination of leukocyte subsets other than for medical purposes; chemicals components being biochemicals for producing radio-labelled monoclonal antibodies for industrial or scientific purposes; proteins for detecting antibodies other than for medical purposes; ] monoclonal antibodies for industrial use; monoclonal antibody reagents, other than for medical use; antigens and antibodies being biochemicals for diagnostic use not for medical purposes; immunological antibodies, being biochemicals, other than for medical use; tagged antibodies being biochemicals for scientific use; [ monoclonal antibodies for qualitative determination of leukocyte subsets other than for medical purposes; linkage compounds being biochemicals for scientific purposes for coupling of radioactive compounds to antibodies; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; ] biochemicals, namely, monoclonal antibodie...

Scientific research; technological services being antibody engineering and design; industrial analysis and research services in the nature of laboratory research and new product design services relating to the production of monoclonal antibodies
yumab

General Information


Serial Number79191669
Word MarkYUMAB
Filing DateMonday, April 25, 2016
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, September 27, 2024
Registration Number5238680
Registration DateTuesday, July 11, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements


Goods and ServicesAntibodies, antibody fragments and antigens in the nature of pharmaceuticals for the treatment of cancer, haematopoietic diseases, autoimmune diseases, neurodegenerative diseases, metabolic diseases, eye diseases, infections, diseases of heart and circulation, bone diseases, transplantation, sepsis, intoxications, and adverse drug reactions
Goods and Services[ Monoclonal antibodies for quantitative determination of leukocyte subsets other than for medical purposes; chemicals components being biochemicals for producing radio-labelled monoclonal antibodies for industrial or scientific purposes; proteins for detecting antibodies other than for medical purposes; ] monoclonal antibodies for industrial use; monoclonal antibody reagents, other than for medical use; antigens and antibodies being biochemicals for diagnostic use not for medical purposes; immunological antibodies, being biochemicals, other than for medical use; tagged antibodies being biochemicals for scientific use; [ monoclonal antibodies for qualitative determination of leukocyte subsets other than for medical purposes; linkage compounds being biochemicals for scientific purposes for coupling of radioactive compounds to antibodies; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; ] biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; proteins for binding antibodies other than for medical purposes; monoclonal antibodies for scientific use; [ linkage compounds being biochemicals for scientific purposes for coupling antibodies to radio nuclides; monoclonal antibodies for research into haematopoietic systems other than for medical purposes; ] reagents for use in development of monoclonal antibodies other than for medical or veterinary purposes; [ components for producing radio-labelled antibody fragments for industrial or scientific purposes being biochemicals; ] tagged antibodies being biochemicals for laboratory use; reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) other than for medical or veterinary purposes comprised primarily of biochemicals
Goods and ServicesScientific research; technological services being antibody engineering and design; industrial analysis and research services in the nature of laboratory research and new product design services relating to the production of monoclonal antibodies

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, September 16, 2016
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 16, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 16, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameYUMAB GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressBraunschweig 38124
DE

Party NameYUMAB GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameYUMAB GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Thursday, September 15, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 16, 2016ASSIGNED TO EXAMINER
Tuesday, September 20, 2016APPLICATION FILING RECEIPT MAILED
Monday, September 26, 2016NON-FINAL ACTION WRITTEN
Tuesday, September 27, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 28, 2016REFUSAL PROCESSED BY MPU
Wednesday, September 28, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, October 16, 2016REFUSAL PROCESSED BY IB
Saturday, March 18, 2017EXAMINERS AMENDMENT -WRITTEN
Saturday, March 18, 2017EXAMINER'S AMENDMENT ENTERED
Saturday, March 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 20, 2017EXAMINERS AMENDMENT MAILED
Wednesday, April 5, 2017NOTICE OF PUBLICATION
Wednesday, April 5, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 5, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, April 21, 2017ASSIGNED TO EXAMINER
Saturday, April 22, 2017NOTIFICATION PROCESSED BY IB
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, October 11, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, October 20, 2017FINAL DISPOSITION PROCESSED
Friday, October 20, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 10, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 15, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, February 18, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 10, 2023TEAS SECTION 71 & 15 RECEIVED
Monday, March 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 3, 2024POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Friday, September 27, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Friday, September 27, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Tuesday, September 17, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED